[ad_1] <br><img src="https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2194795164_7c52a5-e1738781450840.jpg?w=2048" /><br>Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings. <a href="https://fortune.com/2025/02/05/pfizer-merck-promising-prognosis-investors-faulty-forecasts/">Read More</a> <br><a href="https://fortune.com/2025/02/05/pfizer-merck-promising-prognosis-investors-faulty-forecasts/">Read More </a>